Cibus Q1 revenue rises and beats analyst estimates

Cibus

14/05/2026 21:25

Overview

U.S. agtech firm's Q1 revenue rose and beat analyst expectations

Net loss narrowed from prior year, driven by cost cuts and no goodwill impairment

Company raised $37 mln in equity during the quarter to support operations

Outlook

Cibus targets initial LATAM Rice herbicide tolerance launch in 2027, U.S. launch in 2029

Company expects annual net cash usage of about $30 mln or less in 2026

Company expects existing cash to fund operations into late Q1 2027

Result Drivers

PROGRAM REVENUE - Revenue increased year-over-year, which the company attributed to progressing activities and timing of payments across its Rice herbicide tolerance and Sustainable Ingredients programs

RICE PROGRAM MILESTONES - Rice herbicide tolerance program advanced toward commercialization with new agreements and regulatory progress in Latin America and other markets

SUSTAINABLE INGREDIENTS EXPANSION - Expanded R&D activities and increased revenue in Sustainable Ingredients program following contract amendment

Company press release: ID:nGNXc7f3y6

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Beat
$1.68 mln
$1.62 mln (3 Analysts)
Q1 Net Income
-$21.22 mln
Q1 Income from Operations
-$12.12 mln
Q1 Operating Expenses
$13.80 mln
Q1 Pretax Profit
-$21.22 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"

Wall Street's median 12-month price target for Cibus Inc is $16.00, about 999.7% above its May 13 closing price of $1.46

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)